Shopping Cart
- Remove All
Your shopping cart is currently empty
TGFβ1-IN-3
🥰Excellent
Catalog No. T75005Cas No. 2883813-58-7
TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF).
TGFβ1-IN-3
🥰Excellent
Purity: 99.47%
Catalog No. T75005Cas No. 2883813-58-7
TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $82 | In Stock | |
| 5 mg | $203 | In Stock | |
| 10 mg | $291 | In Stock | |
| 25 mg | $453 | In Stock | |
| 50 mg | $625 | In Stock | |
| 100 mg | $826 | In Stock | |
| 200 mg | $1,110 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreBatch Information
Select Batch
Purity:99.47%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | TGFβ1-IN-3, a diarylhydrazone derivative, inhibits fibroblast activation and proliferation, positioning it as a candidate compound for the treatment of idiopathic pulmonary fibrosis (IPF). |
| In vitro | TGFβ1-IN-3 (compound 44) inhibits NIH-3T3 cells with an IC50 of 0.57 μM. At 10 μM for 24 hours, it inhibits TGF-β1-induced abnormal activation of NIH-3T3 and A549 cells, as well as migration and epithelial-mesenchymal transition (EMT) of A549 cells. TGFβ1-IN-3 binds to STAT3, interacting with Ile659, while the hydrophilic piperidine forms intermolecular forces with Ser636, Arg609, and Pro639. The nitrofuran of TGFβ1-IN-3 interacts with Lys658.[1] |
| In vivo | TGFβ1-IN-3 (compound 44) administered orally at 30-60 mg/kg once daily for 22 days in C57BL/6 mice slows IPF progression and enhances lung function, potentially reversing pulmonary fibrosis in a treatment model.[1] |
| Molecular Weight | 442.51 |
| Formula | C23H30N4O5 |
| Cas No. | 2883813-58-7 |
| Smiles | C(=N/NC(=O)C1=CC=C(OCCCCCCN2CCCCC2)C=C1)\C=3OC(N(=O)=O)=CC3 |
| Color | Yellow |
| Appearance | Solid |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (101.69 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy TGFβ1-IN-3 | purchase TGFβ1-IN-3 | TGFβ1-IN-3 cost | order TGFβ1-IN-3 | TGFβ1-IN-3 chemical structure | TGFβ1-IN-3 in vivo | TGFβ1-IN-3 in vitro | TGFβ1-IN-3 formula | TGFβ1-IN-3 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.